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Development and Implementation of Clinical Practice 
Guidelines: Current Status in Korea
Documentation of unexplained geographic variations in medical practices and use of 
inappropriate interventions has led to the proliferation of clinical practice guidelines. With 
increased enthusiasm for guidelines, evidence exists that clinical practice guidelines often 
influence clinical practices or health outcomes. Their successful implementation may 
improve the quality of care by decreasing in appropriate variation and expediting the 
application of effective advances to healthcare practices. In Korea, physicians and 
healthcare professionals have begun to take interests in clinical practice guidelines. 
Currently, over 50 practice guidelines have been developed through professional academic 
organizations or via other routes; however, the quality of the guidelines is unsatisfactory, 
implementation in clinical settings is incomplete, and there is insufficient infrastructure to 
develop clinical practice guidelines. Korea must develop policies and invest resources to 
enhance the development and implementation of clinical practice guidelines.
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ORIGINAL ARTICLE
INTRODUCTION
Clinical practice guidelines can be defined as, “systematically 
developed statements to assist practitioners and patient deci-
sions about appropriate healthcare for specific circumstances” 
(1). The purpose of clinical practice guidelines is to provide as-
sistance for decision-making between practitioners and patients 
under healthcare (2). Clinical practice guidelines are developed 
to improve the quality of care by providing scientific informa-
tion for decision-making and by providing a description of de-
tails for appropriate practices. 
  The backgrounds from which clinical practice guidelines are 
emerging are as follows: 
1) There is increasing uncertainty about the effectiveness of 
new medical technologies that are rapidly implemented 
in clinical practice. 
2) Variations in the medical practices such as surgery rate, 
admission rate, and medication dosage rate are unex-
plained; however, there is insufficient scientific evidence 
to reconcile these variations. 
3) Regarding healthcare spending, the need to induce proper 
behavior by healthcare providers is emerging because 
decisions by physicians have considerable discretion.
  Clinical practice guidelines inform physicians on beneficial 
types of intervention and effective treatment methods versus 
those that are dangerous or ineffective treatments. In addition, 
by presenting various alternatives in patient management, they 
summarize the pros and cons, offer possible consequences in 
an objective manner, and provide physicians with the latest in-
formation through clearly stated recommendations. This can 
help prompt confidence in physicians and their choice of treat-
ment. Furthermore, clinical practice guidelines can assist phy-
sicians as well as patients by providing information on the best 
treatments that enables them to make informed decisions and 
improve treatment compliance. 
  Clinical practice guidelines are considered effective tools to 
shorten the gap between practitioners’ medical care and scien-
tific evidence. During the past several decades, the global de-
velopment and implementation of clinical practice guidelines 
to improve the quality of medical care has increased (3).
  The purpose this article was to investigate current status of 
development and implementation of clinical practice guideline 
in Korea.
CLINICAL PRACTICE GUIDELINES IN GENERAL
Effects on healthcare practice
Though some studies do not show the positive relationships, 
many previous studies on clinical practice guidelines show that 
clinical practice guidelines can provide effective methods to 
change the process of healthcare services and contribute to im-
proving healthcare outcomes (4). Existing study results of the Ahn HS and Kim HJ  •  Clinical Practice Guidelines in Korea
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cases in which clinical practice guidelines was effective in the 
healthcare process and treatment results are as follows:
1) Many previous studies examined whether clinical practice 
guidelines contribute to promoting appropriate medical 
care. The majority of studies suggest clinical practice guide-
lines have a positive effect. A survey by the American Col-
lege of Physicians (ACP) showed that 60% of the members 
felt that clinical practice guidelines had positive effects on 
decisions by physicians (5). In another example, the study 
on the effectiveness of guidelines for upper respiratory in-
fection treatments showed that clinical practice guideline-
driven treatment reduced the dosage of antibiotics, while 
the symptom reduction times of the test and control groups 
were similar (6).
The results of evaluation of the effectiveness of clinical prac-
tice guidelines for treating cystitis have shown that the uri-
nalysis rate, urine culture rate, number of hospital visits of 
the patients subjected to clinical practice guidelines were 
reduced, and the dosage rate of antibiotics recommended 
by clinical practice guidelines were increased (7).
2) The effects of clinical practice guidelines differ with the par-
ticipation level of physicians and the contents of clinical 
practice guidelines (8).
a. The physicians who participated in developing clinical 
practice guidelines tend to abide by clinical practice 
guidelines more than colleagues who did not partici-
pate.
b. Specific clinical practice guidelines influence the be-
havior of physicians more than non-specific clinical 
practice guidelines.
3) The effectiveness of clinical practice guidelines can differ 
by the policies and environment of the hospitals at which 
the physicians work. When an institution initiates a hospi-
tal-wide program that evaluates physician performance 
based on guidelines and recommends the use of clinical 
practice, physicians often resorted to the use of clinical prac-
tice guidelines in actual practice.
4) Implementation of clinical practice guidelines resulted in 
reduced medical care costs as well as improved health out-
comes. Based on a study on the economic benefits of clini-
cal practice guidelines for stroke patients, patients who were 
treated according to clinical practice guidelines incurred 
lower treatment costs than others and a tangible reduction 
in the use of hospital resources. The patients treated with 
the clinical practice guidelines had improved life expectan-
cy and the degree of disability was less severe.
5) The result is that clinical practice guidelines benefit doctors, 
patients, and clinical researchers. Clinical practice guide-
lines improve the quality of medical decisions during treat-
ment and, clinical practice guidelines facilitate the improve-
ment of health outcomes through the promotion of proven 
and effective treatments and the avoidance of ineffective 
treatments.
Methods of development 
Clinical practice guidelines emerged about one hundred years 
ago and were first based on the personal testimonies and opin-
ions of at individual hospitals. The documentation of these tes-
timonies and opinions formed the prototypes of the current 
guidelines. The two main approaches to creating Clinical Prac-
tice Guidelines are the consensus-based approach and the evi-
dence-based approach. Until the 1980s, the consensus-based 
approach was used more often and was based on experts dis-
cussing and debating particular topics, through which treat-
ment recommendations would be derived. However, this ap-
proach often included recommendations with unproven effec-
tiveness because the experts included the preferred treatment 
methods they were personally accustomed to. Accordingly, there 
are weaknesses stemming from the arbitrary recommendations, 
difficulty in propagation and potential controversial topics with 
questionable validity.
  The evidence-based approach developed parallel to evidence-
based medicine and was highly endorsed since it addressed the 
weaknesses of the consensus-based approach (9). With the evi-
dence based approach, literature could be systematically searched 
through literature-search software that helped to eliminate the 
flaws of evidence selection (10). In addition, with meta-analyses 
becoming more common, the methods for grading evidence 
becoming formalized and influential archives such as the Co-
chrane database being established, the evidence-based approach 
gained more credibility and its recommendations became more 
convincing. Currently, the evidence-based approach is domi-
nant because the advantages of a comprehensive literature se-
lection, evaluation, and recommendation derivation (11).
Activities in developed countries
In Europe and North America, the development and implemen-
tation of clinical practice guidelines were initiated two decades 
ago and are still actively pursued. Thus, the experience of these 
regions provide valuable lessons. The important elements that 
appear in the policies of the European and North American coun-
tries regarding clinical practice guidelines are as follows (12):
•  The development of clinical practice guidelines are connect-
ed to policies of that improve the quality of healthcare.
•  An evidence based approach is used to develop most clini-
cal practice guidelines.
•  Development of clinical practice guidelines is tightly linked 
to implementation and dissemination strategies.
  In these nations, significant effort is put into the development 
of clinical practice guidelines as well as implementation and 
dissemination (13). These implementation and dissemination 
strategies include publishing educational literature, conducting Ahn HS and Kim HJ  •  Clinical Practice Guidelines in Korea
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conferences, holding discussions among clinical opinion lead-
ers, and developing reminder systems (14). Audits and finan-
cial incentives are also included.
  In order to do this, developed nations have set up national or-
ganizations or programs for clinical practice guidelines (Table 1).
  These clinical practice guideline programs have standards 
for the quality of clinical practice guidelines; in addition, guide-
line clearing houses have been built for the purpose of their dis-
semination (15).
CURRENT STATUS OF CLINICAL PRACTICE 
GUIDELINES IN KOREA
In Korea, physicians, healthcare professionals, and policy mak-
ers have had recent and increased interest in clinical practice 
guidelines and have initiated discussions within the healthcare 
community. Currently, about 70 clinical practice guidelines have 
been developed through professional academic organizations 
(Table 2) (16).
Characteristics of Korean clinical practice guidelines
We have analyzed 52 guidelines included in the clinical practice 
information system. The average development time for a clini-
cal practice guideline is 7-12 months and the professionals in-
volved in clinical practice guideline development were mostly 
physicians of one specialty within the same medical field. Multi-
disciplinary groups of practitioners involved in clinical practice 
guideline development are relatively rare. Of the development 
methods, the adaptation of foreign guidelines were the most 
common (23.1%), followed by consensus among specialists (19.2), 
and then by evidence based methods (15.4%); in addition, the 
combination of these methods was also common (21.2%). The 
cost of developing clinical practice guidelines came from the 
internal budgets of academic organizations, with development 
amounts ranging from $10,000 and $30,000. Over 50% of aca-
demic organizations either plan to or have gone through revi-
sions (17) (Table 3).
  Through assessing the quality of guidelines using the AGREE 
method, the average score of the six domains were between 50 
to 70 points and was relatively low compared to other nations.
Dissemination and implementation of clinical practice 
guidelines
The dissemination methods for clinical practice guidelines are 
mainly in forms of printed material (28.0%) or presentations at 
academic proceedings (22.7%), and other methods of dissemi-
nation include dissemination at academic proceedings. A total 
of 32.7% of academic associations claimed to have a planned 
budget to disseminate clinical practice guidelines; however, over 
67% did not have a separate budget for dissemination. 
  The awareness and implementation of guidelines among 
physicians was not high (18). In regards to the clinical practice 
guidelines for the treatment of childhood asthma, less than 20% 
attended the educational course for clinical practice guidelines 
and about 20% examined the use of clinical practice guidelines. 
A total of 70% of the pediatricians were aware of the clinical prac-
tice guidelines; however, only a small portion of them actually 
used the guidelines. Conducting educational training for guide-
lines was infrequent. In a survey of pediatricians, the lack of pro-
motion and training on clinical practice guidelines were point-
ed out as necessary.
Problems in developing clinical practice guidelines in Korea
The problems in developing clinical practice guidelines are as 
follows:
•  There is a lack of interdisciplinary approaches to develop 
clinical practice guidelines.
•  There is an intention to use and evidence based approach; 
however, guidelines that detail rigorous evidence based 
approaches are scarce.
•  They want reflect the situations in Korea; however, it is not 
possible due to insufficient domestic research. 
•  Recommendations are made through a consensus of experts 
with an unclear connection between recommendations and 
evidence. 
•  Within development groups, there were limited methodol-
Table 1. Guideline agencies in several countries
Country Name of organization Type of organization Web site
Australia National Health and Medical Research Council (NHMRC) National government www.health.gov.ac./hfs/nhmrc 
Canada Canadian Medical Association (CMA Infobase)
Centres for Health Evidence (CHE)
Professional www.cche.net
Scotland Scottish Intercollegiate Guidelines Network (SIGN) Professional www.sign.ac.uk
England National Institute for Health and Clinical Excellence (NICE) Professional www.nice.org.uk
France HAS (Haute Autoroite De Sante) National government www.has-sonte.fr
Germany  AEZQ/AQuMed Guideline Link Collection (AGLC) National government www.leitlinien.de
Netherlands Dutch Institute for Healthcare Improvement (CBO) Professional www.cbo.nl
New Zealand New Zealand Guideline Group (NZGG) National but not government www.nzgg.org.nz
United States US Preventive Services Task Force (USPSTF) National government www.uspreventiveservicestaskforce.org
Singapore Singapore Clinical Practice Guidelines National government www.moh.gov.sg
Japan Japan Council for Quality Healthcare (JCQHC) National semi government http://minds.jcqhc.or.jpAhn HS and Kim HJ  •  Clinical Practice Guidelines in Korea
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ogists with detailed techniques (19).
ISSUES RELATED TO CLINICAL PRACTICE 
GUIDELINES IN KOREA
Issues regarding the development of implementation of guide-
lines in Korea can be summed up as:
Concerns among the healthcare providers
Many physicians in Korea are critical of clinical practice guide-
lines. According to a survey more than 70% of physicians agreed 
that CPG’s intended to improve quality of healthcare and were 
helpful in making good clinical decisions and improving good 
educational tools. However, over 50% of physicians said that it 
decreased healthcare costs, lowered reimbursements to physi-
cians, challenged the autonomy of physicians, and was too rigid 
to apply to individual patients (Table 4).
  Their concerns can be summarized as guidelines that could 
possibly impede the creativity and diversity of practice, be used 
as an external evaluation and assessment tool, and be used 
against doctors as a basis for legal action. 
  Clinical practice guidelines will improve the quality of medi-
Table 2. Korean clinical practice guideline by subjects
Category            Guideline subjects Academic societies who published guideline
Gastroinstestinal system Diagnostic endoscopy
Therapeutic endoscopy
Intestinal tuberculosis
Behcet’s enteritis
Ulcerative colitis
Crohn’s disease
The Korean Society of Gastrointestinal Endoscopy
 
The Korean Society of Gastroenterology
Liver Chronic hepatitis B
Chronic hepatitis C
Liver cirrhosis
Hepatocellular carcinoma
The Korean Association for the Study of the Liver
The Korean Liver Cancer Study
Respiratory system Asthma
Tuberculosis
Pneumonia
COPD
Lung cancer
The Korean Academic of Tuberculosis and Respiratory Diseases
 
 
 
Korean Association for the study of Lung Cancer
Neurology & psychiatry Alzheimer’s disease
Bipolar disorder
Schizophrenia
Depressive disorder
Post traumatic stress syndrome
Stroke
Stroke rehabilitation
Facial nerve palsy
Korean Association for Geriatric Psychiatry
Korean Neuropsychiatric Association
Korean Academy of Anxiety Disorder, Korean college of Neuropsychopharmacology
Korean Stroke Society
The Korean Otologic Society
Cardiovascular system Hypertension The Korean Society of Hypertension
Musculoskeletal system Osteoporosis
Nerve block
The Korea Society of Bone Metabolism
The Korea Pain Society
Genitourinary system Impotence
Bladder tumor
Gynecologic cancer
Urinary tract infection
Dyslipidemia and impotence
Benign prostate hyperplasia
Kidney disease
Korean Society for Sexual Medicine and Andrology
The Korean Urological Association
The Korean Society of Gynecologic Oncology and Colposcopy
Korean Society of Pediatric Nephrology
The Korean Urological Association
The Korean Urological Association
The Korean Society of Nephrology
Endocrine system Diabetes
Hormonal replacement therapy
Korean Diabetes Association
Korean Society of Obestetrics and Gymecology
Infection Vaccination
Nosocomial infection
Meningococcal meningitis
The Korean Pediatric Society
Korean Society for Nosocomial Infection Control
The Korean Society of Menopause
Oncology Bladder tumor
Gynecologic cancer
Cancer screening
Malignant pain control
Breast cancer
The Korean Urological Association
The Korean Society of Gynecologic Oncology and Colposcopy
Korean Medical Association
Ministry of Health & Wellfare
Korean Breast Cancer Society
Nephrology Kidney disease The Korean Society of Nephrology
Otolaryngology Allergic
Sinusitis
Chronic otitis media
The Korean Academy of Asthma, Allergy and Clinical Immunology
The Korean Rhinologic Society
The Korean Otologic Society
Characteristics of Korean Clinical Practice Guidelines.Ahn HS and Kim HJ  •  Clinical Practice Guidelines in Korea
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cal care and are critical tools to implement evidence-based med-
icine that can only be achieved through the active participation 
of the practitioners to develop and utilize clinical practice guide-
lines. In Korea, it is necessary for providers to properly recognize 
guidelines in order to further expand clinical practice guidelines 
(20). To stimulate the proper recognition of guidelines, there 
needs to be a mechanism to include the providers in the devel-
opment of clinical practice guidelines and logistical support.
Reflection of the situation in Korea and proliferation of 
domestic research
One of the missions in the development of clinical practice guide-
lines is to properly represent the Korean context. Reflecting the 
domestic situation includes understanding the epidemiological 
characteristics of a disease and properly assessing the effective-
ness of interventions in Korea. However, we cannot represent 
the situation in Korea because of insufficient clinical research 
and have to resort to data from other nations. Therefore, we need 
to proliferate domestic research to eliminate this problem. 
  While it is possible to conduct comprehensive literature search-
es for international literature using PubMed, Embase, and Co-
chrane Library databases, the search for domestic literature is 
difficult with an electronic database and in most cases physi-
cians have to resort to a manual paper search. It is necessary to 
build a searchable database that effectively aids in a compre-
hensive search of the domestic literature. 
De novo development or adaptation of international 
guidelines
Since most data for guidelines are from international research, 
a question is raised on whether it is necessary to create de novo 
development or if we can adapt international guidelines that 
cost less time and money. It would make strategic sense to de-
velop guidelines based on increased domestic research. How-
ever, there is a school of thought that makes a strong and valid 
argument on the effectiveness of the evaluation of the quality of 
internationally developed guidelines and the adaptation of good 
quality guidelines. When adapting international guidelines, it 
would be necessary to establish acceptance criteria on the re-
quired information and processes. It would also be necessary 
to define standards to establish priorities to determine whether 
to develop de novo or adapt international clinical practice guide-
lines (18). 
Government’s policies and support
The investment of significant human and financial resources is 
required for the development of sound quality clinical practice 
guidelines. Currently, there exists insufficient infrastructure to 
develop clinical practice guidelines and investments are required 
to develop sound quality clinical practice guidelines. For this, 
the government must be instrumental and provide support for 
professional staff that can allocate an adequate budget to estab-
lish systematic clinical practice guideline programs. Korea needs 
to establish policies on how to develop, expand, and implement 
clinical practice guidelines. These policies require priorities to 
develop clinical practice guidelines (determined in concert by 
the medical community, insurance industry, and consumer 
groups), a system to evaluate the quality and effect of clinical 
practice guidelines, and support functions for the evaluation, 
Table 3. General characteristics of clinical practice guidelines in Korea
Characteristics No. (%)
Duration of development (mo)
   1-6 
   7-12 
   13-24 
   Over 25 
   Unknown
 
12 (23.1)
24 (46.2)
  6 (11.5)
  6 (11.5)
4 (7.7)
Cost of development (million USD)
   0.99 
   1-1.99 
   2 
   Unknown
 
10 (19.2)
14 (26.9)
12 (23.1)
16 (30.8)
Development methods
   Evidence based methods
   Adaptation of foreign guidelines
   Consensus among specialists
   Mixed
   Unknown
 
8 (15.4)
12 (23.1)
10 (19.2)
11 (21.2)
11 (21.2)
Number of involved specialists
   1
   2
   3
   4
   5
   Unknown
 
24 (46.2)
12 (23.1)
  6 (11.5)
  6 (11.5)
3 (5.8)
1 (1.9)
Dissemination methods 
   Sent out in printed forms 
   Sent out in CD forms 
   Sent out through the internet
   Posted in journals
   Presentations at academic proceedings
   Clinical Practice Guidelines education training 
 
  52 (100.0)
- (-)
- (-)
  8 (15.4)
22 (42.3)
10 (19.2)
Table 4. Korean physician’s attitude for clinical practice guidelines
Characteristic Agree Disagree Do not know
Intended to improve the quality of care 561 (78.8) 105 (14.8) 46 (6.5)
Helpful in making good clinical decisions 617 (86.7)   76 (10.7) 19 (2.7)
Helpful to improve good educational tools 615 (86.4)   83 (11.7) 14 (2.0)
Intended to decrease healthcare costs and lower reimbursements to physicians 418 (58.7) 207 (29.0)   87 (12.3)
A challenge to the autonomy of physicians  446 (62.6) 212 (29.8) 54 (7.6)
Too rigid to apply to individual patients and oversimplified 422 (59.2) 216 (30.4)   74 (10.4)Ahn HS and Kim HJ  •  Clinical Practice Guidelines in Korea
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management, and propagation of diverse guidelines by a Guide-
line Clearing House. Clinical practice guidelines are an effective 
means to change the process of healthcare services; however, 
they could adversely affect the quality of medical care and the 
effectiveness of the healthcare system that result in the waste of 
resources if quality clinical practice guidelines are not developed. 
Therefore, a careful, prudent decision-making is required. 
Human resources for evidence-based medicine methods
Methods for Evidence-based medicine are key for development 
of clinical practice guidelines; however, there are an insufficient 
number of professionals with relevant experience. It is neces-
sary to secure and nurture qualified personnel with pertinent 
experience for evidence-based medicine and systematic reviews 
are required in the development of clinical practice guidelines. 
It is also necessary to develop domestically feasible evidence-
based methods adapted from researched developed by inter-
national guideline agencies or associations that can be distrib-
uted nationally.  
CONCLUSION
Clinical practice guidelines must be developed by reasonable 
and well-planned methods to provide required support in the 
fields where actual treatments are provided. Therefore, clinical 
practice guidelines must provide broad, critical, and unbiased 
information in regards to the benefits and limitations of diverse 
diagnoses and treatment methods. This way, doctors who pro-
vide treatments can effectively utilize clinical practice guide-
lines in individual decision-making for patient treatment. In all 
previous research, clinical practice guidelines are presented as 
capable to modify the behaviors of practitioners and improve 
treatment results. In Korea, while the activities of developing 
clinical practice guidelines are vitalized, we must develop and 
find execution ideas that are appropriate for the current condi-
tions of the nation by fully considering research results. For this, 
a policy-backed support by the government is required; it is now 
time for the medical community and government to cooperate 
towards an important endeavor. 
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